Oncolytics Biotech Inc. Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: May 23, 2025 · CIK: 1129928
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
ONCOLYTICS BIOTECH INC (ONCY) filed a 6-K on 5/23/25. Standard foreign issuer report.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on May 23, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates in the Pharmaceutical Preparations sector. This filing is made pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Oncolytics Biotech Inc.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate a change in risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer of the report
- 001-38512 (company) — SEC File Number
- 25979331 (company) — Film Number
- May 2025 (date) — Reporting period for the 6-K
- 20250523 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is May 23, 2025.
What is the principal executive office address of Oncolytics Biotech Inc.?
The principal executive offices are located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
Does Oncolytics Biotech Inc. file an annual report on Form 20-F or 40-F?
Oncolytics Biotech Inc. indicates it files its annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Oncolytics Biotech Inc.?
The SIC code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 23, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).